CO2022014130A2 - Cápsulas de gel blando - Google Patents

Cápsulas de gel blando

Info

Publication number
CO2022014130A2
CO2022014130A2 CONC2022/0014130A CO2022014130A CO2022014130A2 CO 2022014130 A2 CO2022014130 A2 CO 2022014130A2 CO 2022014130 A CO2022014130 A CO 2022014130A CO 2022014130 A2 CO2022014130 A2 CO 2022014130A2
Authority
CO
Colombia
Prior art keywords
soft gel
gel capsules
shell composition
solubilizes
certain embodiments
Prior art date
Application number
CONC2022/0014130A
Other languages
English (en)
Spanish (es)
Inventor
Rickey Steve Shelley
Original Assignee
Scherer Technologies Llc R P
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=77771391&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CO2022014130(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Scherer Technologies Llc R P filed Critical Scherer Technologies Llc R P
Publication of CO2022014130A2 publication Critical patent/CO2022014130A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A61K9/4825—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
CONC2022/0014130A 2020-03-18 2022-09-30 Cápsulas de gel blando CO2022014130A2 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202062991354P 2020-03-18 2020-03-18
PCT/US2021/022918 WO2021188773A1 (en) 2020-03-18 2021-03-18 Softgel capsules

Publications (1)

Publication Number Publication Date
CO2022014130A2 true CO2022014130A2 (es) 2022-10-31

Family

ID=77771391

Family Applications (1)

Application Number Title Priority Date Filing Date
CONC2022/0014130A CO2022014130A2 (es) 2020-03-18 2022-09-30 Cápsulas de gel blando

Country Status (11)

Country Link
US (1) US20230172864A1 (cg-RX-API-DMAC10.html)
EP (1) EP4121036A4 (cg-RX-API-DMAC10.html)
JP (2) JP7785682B2 (cg-RX-API-DMAC10.html)
KR (1) KR20220154196A (cg-RX-API-DMAC10.html)
AR (1) AR121608A1 (cg-RX-API-DMAC10.html)
AU (1) AU2021238345A1 (cg-RX-API-DMAC10.html)
BR (1) BR112022018268A2 (cg-RX-API-DMAC10.html)
CA (1) CA3171512A1 (cg-RX-API-DMAC10.html)
CO (1) CO2022014130A2 (cg-RX-API-DMAC10.html)
MX (1) MX2022011549A (cg-RX-API-DMAC10.html)
WO (1) WO2021188773A1 (cg-RX-API-DMAC10.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12697305B2 (en) 2020-06-02 2026-08-04 R.P. Scherer Technologies, Llc Delayed release softgel capsules

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030133939A1 (en) * 2001-01-17 2003-07-17 Genecraft, Inc. Binding domain-immunoglobulin fusion proteins
MXPA05002728A (es) * 2002-09-13 2005-07-25 Cydex Inc Capsulas que contienen composiciones de relleno acuoso estabilizadas con ciclodextrina derivada.
ITMI20022777A1 (it) * 2002-12-27 2004-06-28 Altergon Sa Formulazioni farmaceutiche per ormoni tiroidei e procedimenti per il loro ottenimento.
US20070292523A1 (en) * 2004-09-27 2007-12-20 Joey Moodley Dihydropyrimidine Formulations
CN1872061A (zh) * 2006-04-17 2006-12-06 宛六一 一种药物组合物软胶囊及其制备方法
JP5840668B2 (ja) * 2012-12-07 2016-01-06 富士カプセル株式会社 ロキソプロフェンナトリウム含有軟カプセル用内容物、及び、それを含有する軟カプセル製剤
US10420729B2 (en) * 2013-03-15 2019-09-24 R.P. Scherer Technologies, Llc Abuse resistant capsule
US9504656B2 (en) * 2013-10-21 2016-11-29 Banner Life Sciences, LLC Pharmaceutical compositions for poorly soluble active ingredients
US9326947B1 (en) * 2014-02-28 2016-05-03 Banner Life Sciences Llc Controlled release fumarate esters
WO2015195989A1 (en) * 2014-06-20 2015-12-23 Banner Life Sciences Llc Enteric soft capsule compositions
WO2015200149A1 (en) * 2014-06-23 2015-12-30 Banner Life Sciences Llc All natural enteric soft capsules comprising active ingredients
CA2980165C (en) * 2015-03-26 2021-06-15 Patheon Softgels Inc. Liquisoft capsules
EP3283061A4 (en) * 2015-04-14 2019-04-17 Atossa Genetics Inc. COMPOSITIONS AND METHODS FOR THE TREATMENT OF BREAST DISEASES AND ORGANISM-RELATED ILLNESSES
US20170119680A1 (en) * 2015-10-30 2017-05-04 R.P. Scherer Technologies, Llc Extended release film-coated capsules
IT201800003615A1 (it) * 2018-03-15 2019-09-15 Altergon Sa Formulazioni altamente stabili di ormone tiroideo in capsule molli
CA3092145A1 (en) * 2018-03-15 2019-09-19 R.P. Scherer Technologies, Llc Enteric softgel capsules

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12697305B2 (en) 2020-06-02 2026-08-04 R.P. Scherer Technologies, Llc Delayed release softgel capsules

Also Published As

Publication number Publication date
KR20220154196A (ko) 2022-11-21
CA3171512A1 (en) 2022-09-23
MX2022011549A (es) 2022-10-13
JP2026035788A (ja) 2026-03-04
EP4121036A4 (en) 2024-04-10
EP4121036A1 (en) 2023-01-25
AU2021238345A1 (en) 2022-10-06
WO2021188773A1 (en) 2021-09-23
JP7785682B2 (ja) 2025-12-15
AR121608A1 (es) 2022-06-22
JP2023518245A (ja) 2023-04-28
US20230172864A1 (en) 2023-06-08
BR112022018268A2 (pt) 2022-10-25

Similar Documents

Publication Publication Date Title
ES8504366A1 (es) Perfeccionamientos en un dispositivo para obturar el espacio entre un eje rotatorio y un organo fijo que rodea al eje
JP5192816B2 (ja) 非ゼラチン軟質カプセルシステム
FI944452A0 (fi) Gelatiinikapseli ja menetelmä sen valmistamiseksi
HUP9701111A2 (hu) Töltőanyag lágy zselatin kapszula gyógyszeradagolási formához
ES411206A1 (es) Una disposicion mejorada de embase unitario reactivo con elagua.
CY1118258T1 (el) Εντεροδιαλυτη συνθεση για την παρασκευη περιβληματος μαλακης καψουλας
ES2162922T3 (es) Composicion para administracion colonica de medicamentos.
NO840793L (no) Farmasoeytisk middel
CO5640066A2 (es) Composicion oral que contiene enzimas con estabilidad mejorada
CO2022005947A2 (es) Formulaciones de cápsulas de gelatina blanda no animales, métodos de preparación y métodos de uso de las mismas
MY136678A (en) Capsule and capsule forming method and apparatus
PL362850A1 (pl) Miękkie kapsułki żelowe zawierajace ibuprofen
ATE252376T1 (de) Retinolhaltiges arzneimittel kompatibel mit weichgelatinekapseln
AR121608A1 (es) Cápsulas blandas de gel
AR027748A1 (es) Pequenas esferas o globulos que contienen estavudina y permiten la liberacion controlada de la misma
MX2024000409A (es) Capsula de gelatina blanda.
EP0152292A3 (en) Acetaminophen gelatin capsules
DE69819356D1 (de) Vitamin zusammensetzung
MY142365A (en) Non-gelatin based capsules
CO6220899A2 (es) Composicion liquida para blanquear los dientes, a base de portador de polimero hidrofobo
BR112022024391A2 (pt) Cápsulas de gelatina mole para liberação retardada
MX2021010959A (es) Estabilidad mejorada de ingredientes farmaceuticos activos (api) en capsulas blandas.
HUP9701112A2 (hu) Antiflatulenst tartalmazó töltőanyag lágy zselatin kapszula gyógyszeradagolási formához
WO2004022032A3 (en) Pharmaceutical dosage form comprising a sulfite compound
CO2025011936A2 (es) Cápsulas farmacéuticas osmóticas